Kampo medicines induce formula-dependent changes in the intestinal flora of mice

Kiyoe Takashima, Kaori Munakata, Masahiro Yamamoto, Kenji Watanabe, Kenji Tsuiji, Masahiro Yamamoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Certain ingredients in Kampo medicines are known to be converted into the active form by bacterial flora in the intestine. Conversely, enteric microbiota is supposed to be affected by Kampo medicines, because the medicines comprise numerous compounds with prebiotic and/or antimicrobial properties. However, the effect of Kampo medicines on the bacterial flora has rarely been studied. In this study, the effects of different types of Kampo medicines on bacterial flora were investigated. Male IQI mice were orally treated with juzentaihoto, hochuekkito, kakkonto, and orengedokuto extract solutions (1 g/kg body weight) or water daily for 14 days. To examine the changes in the intestinal microflora, the terminal restriction fragment polymorphism (T-RFLP) method was used. Cluster analyses suggested that T-RFLP profiles of juzentaihoto/hochuekkito (“hozai”) and orengedokuto/kakkonto (“Shazai”) are classified into 2 different clusters in the dendrogram. To examine changes in 5 genera of common bacteria (Bifidobacterium, Lactobacillus, Clostridium, Escherichia coli, and Bacteroides fragilis), real-time PCR was performed. No large-scale changes were observed except for modest but significant decrease in Lactobacillus numbers by juzentaihoto as well as several hundred-fold increase in Escherichia coli numbers by hochuekkito. The present study indicates that DNA-based methods for the analysis of microbiota may pave the way for elucidation of the complicated and pleiotropic influences of the components of Kampo medicines on enteric flora.

Original languageEnglish
Pages (from-to)179-185
Number of pages7
JournalJournal of Traditional Medicines
Volume29
Issue number4
DOIs
Publication statusPublished - 2012

Fingerprint

Kampo Medicine
Microbiota
Lactobacillus
Escherichia coli
Bacteroides fragilis
Prebiotics
Bifidobacterium
Clostridium
Body Water
Intestines
Cluster Analysis
Real-Time Polymerase Chain Reaction
Body Weight
Gastrointestinal Microbiome
Bacteria
DNA
bu-zhong-yi-qi-tang
juzentaihoto

Keywords

  • intestinal flora
  • Kampo medicine
  • terminal restriction fragment length polymorphism (T-RFLP)

ASJC Scopus subject areas

  • Complementary and alternative medicine
  • Drug Discovery

Cite this

Takashima, K., Munakata, K., Yamamoto, M., Watanabe, K., Tsuiji, K., & Yamamoto, M. (2012). Kampo medicines induce formula-dependent changes in the intestinal flora of mice. Journal of Traditional Medicines, 29(4), 179-185. https://doi.org/10.11339/jtm.29.179

Kampo medicines induce formula-dependent changes in the intestinal flora of mice. / Takashima, Kiyoe; Munakata, Kaori; Yamamoto, Masahiro; Watanabe, Kenji; Tsuiji, Kenji; Yamamoto, Masahiro.

In: Journal of Traditional Medicines, Vol. 29, No. 4, 2012, p. 179-185.

Research output: Contribution to journalArticle

Takashima, K, Munakata, K, Yamamoto, M, Watanabe, K, Tsuiji, K & Yamamoto, M 2012, 'Kampo medicines induce formula-dependent changes in the intestinal flora of mice', Journal of Traditional Medicines, vol. 29, no. 4, pp. 179-185. https://doi.org/10.11339/jtm.29.179
Takashima, Kiyoe ; Munakata, Kaori ; Yamamoto, Masahiro ; Watanabe, Kenji ; Tsuiji, Kenji ; Yamamoto, Masahiro. / Kampo medicines induce formula-dependent changes in the intestinal flora of mice. In: Journal of Traditional Medicines. 2012 ; Vol. 29, No. 4. pp. 179-185.
@article{b189bb9b6b7c4931b2a0017487acd33b,
title = "Kampo medicines induce formula-dependent changes in the intestinal flora of mice",
abstract = "Certain ingredients in Kampo medicines are known to be converted into the active form by bacterial flora in the intestine. Conversely, enteric microbiota is supposed to be affected by Kampo medicines, because the medicines comprise numerous compounds with prebiotic and/or antimicrobial properties. However, the effect of Kampo medicines on the bacterial flora has rarely been studied. In this study, the effects of different types of Kampo medicines on bacterial flora were investigated. Male IQI mice were orally treated with juzentaihoto, hochuekkito, kakkonto, and orengedokuto extract solutions (1 g/kg body weight) or water daily for 14 days. To examine the changes in the intestinal microflora, the terminal restriction fragment polymorphism (T-RFLP) method was used. Cluster analyses suggested that T-RFLP profiles of juzentaihoto/hochuekkito (“hozai”) and orengedokuto/kakkonto (“Shazai”) are classified into 2 different clusters in the dendrogram. To examine changes in 5 genera of common bacteria (Bifidobacterium, Lactobacillus, Clostridium, Escherichia coli, and Bacteroides fragilis), real-time PCR was performed. No large-scale changes were observed except for modest but significant decrease in Lactobacillus numbers by juzentaihoto as well as several hundred-fold increase in Escherichia coli numbers by hochuekkito. The present study indicates that DNA-based methods for the analysis of microbiota may pave the way for elucidation of the complicated and pleiotropic influences of the components of Kampo medicines on enteric flora.",
keywords = "intestinal flora, Kampo medicine, terminal restriction fragment length polymorphism (T-RFLP)",
author = "Kiyoe Takashima and Kaori Munakata and Masahiro Yamamoto and Kenji Watanabe and Kenji Tsuiji and Masahiro Yamamoto",
year = "2012",
doi = "10.11339/jtm.29.179",
language = "English",
volume = "29",
pages = "179--185",
journal = "Journal of Traditional Medicines",
issn = "1880-1447",
publisher = "Medical and Pharmaceutical Society for WAKAN-YAKU",
number = "4",

}

TY - JOUR

T1 - Kampo medicines induce formula-dependent changes in the intestinal flora of mice

AU - Takashima, Kiyoe

AU - Munakata, Kaori

AU - Yamamoto, Masahiro

AU - Watanabe, Kenji

AU - Tsuiji, Kenji

AU - Yamamoto, Masahiro

PY - 2012

Y1 - 2012

N2 - Certain ingredients in Kampo medicines are known to be converted into the active form by bacterial flora in the intestine. Conversely, enteric microbiota is supposed to be affected by Kampo medicines, because the medicines comprise numerous compounds with prebiotic and/or antimicrobial properties. However, the effect of Kampo medicines on the bacterial flora has rarely been studied. In this study, the effects of different types of Kampo medicines on bacterial flora were investigated. Male IQI mice were orally treated with juzentaihoto, hochuekkito, kakkonto, and orengedokuto extract solutions (1 g/kg body weight) or water daily for 14 days. To examine the changes in the intestinal microflora, the terminal restriction fragment polymorphism (T-RFLP) method was used. Cluster analyses suggested that T-RFLP profiles of juzentaihoto/hochuekkito (“hozai”) and orengedokuto/kakkonto (“Shazai”) are classified into 2 different clusters in the dendrogram. To examine changes in 5 genera of common bacteria (Bifidobacterium, Lactobacillus, Clostridium, Escherichia coli, and Bacteroides fragilis), real-time PCR was performed. No large-scale changes were observed except for modest but significant decrease in Lactobacillus numbers by juzentaihoto as well as several hundred-fold increase in Escherichia coli numbers by hochuekkito. The present study indicates that DNA-based methods for the analysis of microbiota may pave the way for elucidation of the complicated and pleiotropic influences of the components of Kampo medicines on enteric flora.

AB - Certain ingredients in Kampo medicines are known to be converted into the active form by bacterial flora in the intestine. Conversely, enteric microbiota is supposed to be affected by Kampo medicines, because the medicines comprise numerous compounds with prebiotic and/or antimicrobial properties. However, the effect of Kampo medicines on the bacterial flora has rarely been studied. In this study, the effects of different types of Kampo medicines on bacterial flora were investigated. Male IQI mice were orally treated with juzentaihoto, hochuekkito, kakkonto, and orengedokuto extract solutions (1 g/kg body weight) or water daily for 14 days. To examine the changes in the intestinal microflora, the terminal restriction fragment polymorphism (T-RFLP) method was used. Cluster analyses suggested that T-RFLP profiles of juzentaihoto/hochuekkito (“hozai”) and orengedokuto/kakkonto (“Shazai”) are classified into 2 different clusters in the dendrogram. To examine changes in 5 genera of common bacteria (Bifidobacterium, Lactobacillus, Clostridium, Escherichia coli, and Bacteroides fragilis), real-time PCR was performed. No large-scale changes were observed except for modest but significant decrease in Lactobacillus numbers by juzentaihoto as well as several hundred-fold increase in Escherichia coli numbers by hochuekkito. The present study indicates that DNA-based methods for the analysis of microbiota may pave the way for elucidation of the complicated and pleiotropic influences of the components of Kampo medicines on enteric flora.

KW - intestinal flora

KW - Kampo medicine

KW - terminal restriction fragment length polymorphism (T-RFLP)

UR - http://www.scopus.com/inward/record.url?scp=85024465749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024465749&partnerID=8YFLogxK

U2 - 10.11339/jtm.29.179

DO - 10.11339/jtm.29.179

M3 - Article

VL - 29

SP - 179

EP - 185

JO - Journal of Traditional Medicines

JF - Journal of Traditional Medicines

SN - 1880-1447

IS - 4

ER -